News ItemNMBio States Position on Patent Reform Act

October 28, 2011 – 

On September 8, 2011 the U.S. Senate passed a patent reform bill, the “Leahy-Smith America Invents Act,” which was subsequently signed into law by President Obama on September 16. The final Senate vote was 89-9, reflecting broad support for patent reform legislation in this Congress-the Senate passed its version of the bill (S. 23) by a vote of 95-5, and the House bill (H.R. 1249) passed by a 304-117 margin. It is widely believed that this patent reform measure is going to usher in considerable changes in how patents are obtained and enforced in the United States.

The recently passed patent reform act, “Leahy-Smith America Invents Act” changes the nature of the patent process from “first to invent” to “first to file”. NMBio presented their views to our congressional delegation in June of this year. We wanted to provide you with the position paper. Please click to view.

Share:
Novo Norodisk

Novo Norodisk

Southwest Labs

Southwest Labs

UPS

UPS

Curia Global

Curia Global

Aerotek

Aerotek

Emera

Emera

Amgen

Amgen

STC UTM

STC UTM

Arrowhead Center

Arrowhead Center

New Mexico Consortium

New Mexico Consortium

Bio

Bio

Burrell College of Osteopathic Medicine

Burrell College of Osteopathic Medicine

Bristol Myers Squibb

Bristol Myers Squibb

Sandia National Laboratories

Sandia National Laboratories

Colliers

Colliers